{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:12:11Z","timestamp":1791933131868,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1038\/ni815","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T17:36:01Z","timestamp":1027877761000},"page":"727-732","source":"Crossref","is-referenced-by-count":152,"title":["Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1"],"prefix":"10.1038","volume":"3","author":[{"given":"Lisa J.","family":"Matthias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia T.W.","family":"Yam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Mai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Vandegraaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Poumbourios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Donoghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Hogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,7,1]]},"reference":[{"key":"BFni815_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0952-7915(01)00300-4","volume":"14","author":"R Konig","year":"2002","unstructured":"Konig, R. Interactions between MHC molecules and co-receptors of the TCR. Curr. Opin. Immunol. 14, 75\u201383 (2002).","journal-title":"Curr. Opin. Immunol."},{"key":"BFni815_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0092-8674(00)81655-4","volume":"99","author":"JG Sodroski","year":"1999","unstructured":"Sodroski, J.G. HIV-1 entry inhibitors in the side pocket. Cell 99, 243\u2013246 (1999).","journal-title":"Cell"},{"key":"BFni815_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0092-8674(85)80105-7","volume":"42","author":"PJ Maddon","year":"1985","unstructured":"Maddon, P.J. et al. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family. Cell 42, 93\u2013104 (1985).","journal-title":"Cell"},{"key":"BFni815_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1432-1033.1990.tb15402.x","volume":"188","author":"RJ Harris","year":"1990","unstructured":"Harris, R.J., Chamow, S.M., Gregory, T.J. & Spellman, M.W. Characterization of a soluble form of human CD4. Eur. J. Biochem. 188, 291\u2013300 (1990).","journal-title":"Eur. J. Biochem."},{"key":"BFni815_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/348411a0","volume":"348","author":"J Wang","year":"1990","unstructured":"Wang, J. et al. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 348, 411\u2013418 (1990).","journal-title":"Nature"},{"key":"BFni815_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/348419a0","volume":"348","author":"SR Ryu","year":"1990","unstructured":"Ryu, S.R. et al. Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature 348, 419\u2013426 (1990).","journal-title":"Nature"},{"key":"BFni815_CR7","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.8493535","volume":"260","author":"RL Brady","year":"1993","unstructured":"Brady, R.L. et al. Crystal structure of domains 3 and 4 of rat CD4: relation to the NH2-terminal domains. Science 260, 979\u2013983 (1993).","journal-title":"Science"},{"key":"BFni815_CR8","doi-asserted-by":"crossref","first-page":"15480","DOI":"10.1016\/S0021-9258(18)66737-7","volume":"261","author":"BA Katz","year":"1986","unstructured":"Katz, B.A. & Kossiakoff, A. The crystallographically determined structures of atypical strained disulfides engineered into subtilisin. J. Biol. Chem. 261, 15480\u201315485 (1986).","journal-title":"J. Biol. Chem."},{"key":"BFni815_CR9","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1021\/ja00315a051","volume":"106","author":"SJ Weiner","year":"1984","unstructured":"Weiner, S.J. et al. A new force field for molecular mechanical simulation of nucleic acids and proteins. J. Am. Chem. Soc. 106, 765\u2013784 (1984).","journal-title":"J. Am. Chem. Soc."},{"key":"BFni815_CR10","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1016\/S0021-9258(18)37859-1","volume":"263","author":"CN Pace","year":"1988","unstructured":"Pace, C.N., Grimsley, G.R., Thomson, J.A. & Barnett, B.J. Conformational stability and activity of ribonuclease T1 with zero, one, and two intact disulfide bonds. J. Biol. Chem. 263, 11820\u201311825 (1988).","journal-title":"J. Biol. Chem."},{"key":"BFni815_CR11","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.1073\/pnas.83.13.4779","volume":"83","author":"HM Ingalls","year":"1986","unstructured":"Ingalls, H.M., Goodloe-Holland, C.M. & Luna, E.J. Junctional plasma membrane domains isolated from aggregating Dictyostelium discoideum amebae. Proc. Natl. Acad. Sci. USA 83, 4779\u20134783 (1986).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni815_CR12","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1074\/jbc.274.4.2416","volume":"274","author":"X-M Jiang","year":"1999","unstructured":"Jiang, X.-M., Fitzgerald, M., Grant, C.M. & Hogg, P.J. Redox control of exofacial protein thiols\/disulfides by protein disulfide isomerase. J. Biol. Chem. 274, 2416\u20132423 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFni815_CR13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1128\/MCB.8.1.466","volume":"8","author":"Y Takebe","year":"1988","unstructured":"Takebe, Y. et al. SR\u03b1 promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8, 466\u2013472 (1988).","journal-title":"Mol. Cell. Biol."},{"key":"BFni815_CR14","doi-asserted-by":"crossref","first-page":"22485","DOI":"10.1016\/S0021-9258(18)41555-4","volume":"268","author":"K Tonissen","year":"1993","unstructured":"Tonissen, K. et al. Site-directed mutagenesis of human thioredoxin. J. Biol. Chem. 268, 22485\u201322489 (1993).","journal-title":"J. Biol. Chem."},{"key":"BFni815_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/331082a0","volume":"331","author":"KC Deen","year":"1988","unstructured":"Deen, K.C. et al. A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature 331, 82\u201384 (1988).","journal-title":"Nature"},{"key":"BFni815_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/0470023473.ch2","volume-title":"The Chemistry of Organic Arsenic, Antimony, and Bismuth Compounds","author":"DB Sowerby","year":"1994","unstructured":"Sowerby, D.B. in The Chemistry of Organic Arsenic, Antimony, and Bismuth Compounds (ed. Patai, S.) 25\u201388 (John Wiley and Sons, New York, NY, 1994)."},{"key":"BFni815_CR17","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1016\/S0021-9258(18)68673-9","volume":"263","author":"M Jauhiainen","year":"1988","unstructured":"Jauhiainen, M., Stevenson, K.J. & Dolphin, P.J. Human plasma lecithin-cholesterol acyltransferase. The vicinal nature of cysteine 31 and cysteine 184 in the catalytic site. J. Biol. Chem. 263, 6525\u20136533 (1988).","journal-title":"J. Biol. Chem."},{"key":"BFni815_CR18","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1110\/ps.9.12.2436","volume":"9","author":"N Donoghue","year":"2000","unstructured":"Donoghue, N., Yam, P.T.W., Jiang, X.-M. & Hogg, P.J. Presence of closely-spaced protein thiols on the surface of mammalian cells. Protein Sci. 9, 2436\u20132445 (2000).","journal-title":"Protein Sci."},{"key":"BFni815_CR19","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1128\/AAC.45.9.2510-2516.2001","volume":"45","author":"N Vandegraaff","year":"2001","unstructured":"Vandegraaff, N. et al. Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: putative inhibitors of HIV-1 integrase. Antimicrob. Agents Chemother. 45, 2510\u20132516 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFni815_CR20","doi-asserted-by":"crossref","first-page":"7517","DOI":"10.1128\/JVI.66.12.7517-7521.1992","volume":"66","author":"R Collman","year":"1992","unstructured":"Collman, R. et al. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol. 66, 7517\u20137521 (1992).","journal-title":"J. Virol."},{"key":"BFni815_CR21","doi-asserted-by":"crossref","first-page":"10310","DOI":"10.1128\/JVI.73.12.10310-10319.1999","volume":"73","author":"CC LaBranche","year":"1999","unstructured":"LaBranche, C.C. et al. Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity. J. Virol. 73, 10310\u201310319 (1999).","journal-title":"J. Virol."},{"key":"BFni815_CR22","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.4049\/jimmunol.152.3.1064","volume":"152","author":"I Nakashima","year":"1994","unstructured":"Nakashima, I. et al. Redox mechanism as alternative to ligand binding for receptor activation delivering disregulated cellular signals. J. Immunol. 152, 1064\u20131071 (1994).","journal-title":"J. Immunol."},{"key":"BFni815_CR23","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1002\/(SICI)1521-4141(199908)29:08<2590::AID-IMMU2590>3.0.CO;2-R","volume":"29","author":"GW Lynch","year":"1999","unstructured":"Lynch, G.W., Sloane, A.J., Rasco, V., Lai, A. & Cunningham, A.L. Direct evidence for native CD4 oligomers in lymphoid and monocytoid cells. Eur. J. Immunol. 29, 2590\u20132602 (1999).","journal-title":"Eur. J. Immunol."},{"key":"BFni815_CR24","doi-asserted-by":"publisher","first-page":"45459","DOI":"10.1073\/pnas.91.10.4559","volume":"91","author":"HJ-P Ryser","year":"1994","unstructured":"Ryser, H.J.-P., Levy, E.M., Mandel, R. & DiSciullo, G.J. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proc. Natl. Acad. Sci. USA 91, 45459\u20134563 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni815_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0065-3233(08)60520-3","volume":"34","author":"JA Richardson","year":"1981","unstructured":"Richardson, J.A. Protein anatomy. Adv. Protein. Chem. 34, 167\u2013339 (1981).","journal-title":"Adv. Protein. Chem."},{"key":"BFni815_CR26","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1021\/ja00214a049","volume":"110","author":"IL Karle","year":"1988","unstructured":"Karle, I.L., Kishore, R., Raghothama, S. & Balaram, P. Cyclic cystine peptides. Antiparallel \u03b2-sheet conformation for the 20-membered ring in Boc-Cys-Val-Aib-Ala-Leu-Cys-NHMe. J. Am. Chem. Soc. 110, 1958\u20131963 (1988).","journal-title":"J. Am. Chem. Soc."},{"key":"BFni815_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1399-3011.1989.tb01005.x","volume":"34","author":"IL Karle","year":"1989","unstructured":"Karle, I.L., Flippen-Anderson, J.L., Kishore, R. & Balaram, P. Cystine peptides. Int. J. Peptide Protein Res. 34, 37\u201341 (1989).","journal-title":"Int. J. Peptide Protein Res."},{"key":"BFni815_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1101\/SQB.1989.054.01.075","volume":"65","author":"AF Williams","year":"1989","unstructured":"Williams, A.F., Davis, S.J., He, Q. & Barclay, A.N. Structural diversity in domains of the immunoglobulin superfamily. Cold Spring Harbor Symp. Quant. Biol. 65, 637\u2013647 (1989).","journal-title":"Cold Spring Harbor Symp. Quant. Biol."},{"key":"BFni815_CR29","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.4049\/jimmunol.142.11.3931","volume":"142","author":"L Kirszbaum","year":"1989","unstructured":"Kirszbaum, L., Sharpe, J.A., Goss, N., Lahnstein, J. & Walker, I.D. The \u03b1-chain of murine CD8 lacks an invariant Ig-like disulfide bond but contains a unique intrachain loop instead. J. Immunol. 142, 3931\u20133936 (1989).","journal-title":"J. Immunol."},{"key":"BFni815_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev.bi.54.070185.001321","volume":"54","author":"A Holmgren","year":"1985","unstructured":"Holmgren, A. Thioredoxin. Annu. Rev. Biochem. 54, 237\u2013271 (1985).","journal-title":"Annu. Rev. Biochem."},{"key":"BFni815_CR31","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/j.1460-2075.1989.tb03436.x","volume":"8","author":"Y Tagaya","year":"1989","unstructured":"Tagaya, Y. et al. ATL-derived factor (ADF), an IL-2 receptor\/Tac inducer homologous to thioredoxin: possible involvement of a dithiol-reduction in the IL-2 receptor induction. EMBO J. 8, 757\u2013764 (1989).","journal-title":"EMBO J."},{"key":"BFni815_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0006-291X(05)81209-4","volume":"175","author":"H Martin","year":"1991","unstructured":"Martin, H. & Dean M. Identification of a thioredoxin-related protein associated with plasma membranes. Biochem. Biophys. Res. Commun. 175, 123\u2013128 (1991).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFni815_CR33","doi-asserted-by":"crossref","first-page":"24161","DOI":"10.1016\/S0021-9258(18)35742-9","volume":"267","author":"A Rubartelli","year":"1992","unstructured":"Rubartelli, A., Bajetto, A., Allavena, G., Wollman, E. & Sitia, R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem. 267, 24161\u201324164 (1992).","journal-title":"J. Biol. Chem."},{"key":"BFni815_CR34","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1006\/bbrc.1996.6015","volume":"230","author":"EE Woolman","year":"1997","unstructured":"Woolman, E.E., Kahan, A. & Fradelizi, D. Detection of membrane associated thioredoxin on human cell lines. Biochem. Biophys. Res. Commun. 230, 602\u2013606 (1997).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFni815_CR35","first-page":"2281","volume":"60","author":"A Soderberg","year":"2000","unstructured":"Soderberg, A., Sahaf, B. & Rosen, A. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma. Cancer Res. 60, 2281\u20132289 (2000).","journal-title":"Cancer Res."},{"key":"BFni815_CR36","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1128\/JVI.69.9.5734-5742.1995","volume":"69","author":"RE Bachelder","year":"1995","unstructured":"Bachelder, R.E., Bilancieri, J., Lin, W. & Letvin, N.L. A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4. J. Virol. 69, 5734\u20135742 (1995).","journal-title":"J. Virol."},{"key":"BFni815_CR37","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/protein\/9.8.671","volume":"9","author":"YH Sanejouand","year":"1996","unstructured":"Sanejouand, Y.H. Normal-mode analysis suggests important flexibility between the two N-terminal domains of CD4 and supports the hypothesis of a conformational change in CD4 upon HIV binding. Protein Eng. 9, 671\u2013677 (1996).","journal-title":"Protein Eng."},{"key":"BFni815_CR38","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.4049\/jimmunol.149.5.1779","volume":"149","author":"LC Burkly","year":"1992","unstructured":"Burkly, L.C. et al. Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. J. Immunol. 149, 1779\u20131787 (1992).","journal-title":"J. Immunol."},{"key":"BFni815_CR39","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1128\/JVI.66.8.4784-4793.1992","volume":"66","author":"JP Moore","year":"1992","unstructured":"Moore, J.P., Sattentau, Q.J., Klasse, P.J. & Burkly, L.C. A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of the human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells. J. Virol. 66, 4784\u20134793 (1992).","journal-title":"J. Virol."},{"key":"BFni815_CR40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/intimm\/8.4.603","volume":"8","author":"H Nakamura","year":"1996","unstructured":"Nakamura, H. et al. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int. Immunol. 8, 603\u2013611 (1996).","journal-title":"Int. Immunol."},{"key":"BFni815_CR41","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1073\/pnas.041624998","volume":"98","author":"H Nakamura","year":"2001","unstructured":"Nakamura, H. et al. Chronic elevation of plasma thioredoxin: Inhibition of chemotaxis and curtailment of life expectancy in AIDS. Proc. Natl. Acad. Sci. USA 98, 2688\u20132693 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni815_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1089\/aid.1992.8.209","volume":"8","author":"M Roederer","year":"1992","unstructured":"Roederer, M., Ela, S.W., Staal, F.J.T. & Herzenberg, L.A. N-acetylcysteine: A new approach to anti-HIV therapy. AIDS Res. Hum. Retroviruses 8, 209\u2013216 (1992).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFni815_CR43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0167-5699(92)90156-2","volume":"13","author":"W Dr\u00f6ge","year":"1992","unstructured":"Dr\u00f6ge, W., Eck, H.-P. & Mihm, S. HIV-induced cysteine deficiency and T-cell dysfunction - a rationale for treatment with N-acetylcysteine. Immunol. Today 13, 211\u2013214 (1992).","journal-title":"Immunol. Today"},{"key":"BFni815_CR44","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1172\/JCI117223","volume":"93","author":"A Bergamini","year":"1994","unstructured":"Bergamini, A. et al. Cystamine potently suppresses in vitro HIV replication in acutely and chronically infected human cells. J. Clin. Invest. 93, 2251\u20132257 (1994).","journal-title":"J. Clin. Invest."},{"key":"BFni815_CR45","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1089\/aid.1995.11.451","volume":"11","author":"W-Z Ho","year":"1995","unstructured":"Ho, W.-Z. et al. Cystamine inhibits HIV type 1 replication in cells of monocyte\/macrophage and T cell lineages. AIDS Res. Hum. Retroviruses 11, 451\u2013459 (1995).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFni815_CR46","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/infdis\/174.1.214","volume":"174","author":"A Bergamini","year":"1996","unstructured":"Bergamini, A. et al. In vitro inhibition of the replication of human immunodeficiency virus type 1 by \u03b2-mercaptoethanol (cysteamine). J. Infect. Dis. 174, 214\u2013218 (1996).","journal-title":"J. Infect. Dis."},{"key":"BFni815_CR47","first-page":"1531","volume":"36","author":"RS Schulof","year":"1986","unstructured":"Schulof, R.S. et al. Treatment of HTLV-III\/LAV-infected patients with D-penicillamine. Arzneim Forsch Drug Res. 36, 1531\u20131534 (1986).","journal-title":"Arzneim Forsch Drug Res."},{"key":"BFni815_CR48","first-page":"184","volume":"36","author":"P Chandra","year":"1986","unstructured":"Chandra, P. & Sarin, P.S. Selective inhibition of replication of the AIDS-associated virus HTLV-III\/LAV by synthetic D-penicillamine. Arzneim Forsch Drug Res. 36, 184\u2013186 (1986).","journal-title":"Arzneim Forsch Drug Res."},{"key":"BFni815_CR49","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1001\/jama.284.2.215","volume":"284","author":"MP D'Souza","year":"2000","unstructured":"D'Souza, M.P., Cairns, J.S. & Plaeger, S.F. Current evidence and future directions for targeting HIV entry: therapeutic and prophylactic strategies. J. Am. Med. Assoc. 284, 215\u2013222 (2000).","journal-title":"J. Am. Med. Assoc."},{"key":"BFni815_CR50","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1089\/aid.1992.8.253","volume":"8","author":"P Li","year":"1992","unstructured":"Li. P. & Burrell, C.J. Synthesis of human immunodeficiency virus DNA in a cell-to-cell transmission model. AIDS Res. Hum. Retroviruses 8, 253\u2013259 (1992).","journal-title":"AIDS Res. Hum. Retroviruses"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ni815.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni815","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni815.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:51:38Z","timestamp":1684435898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ni815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,1]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["BFni815"],"URL":"https:\/\/doi.org\/10.1038\/ni815","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1007507.94406","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,1]]}}}